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ABSTRACT: Six anthelmintic drugs, Ivermectin, Closantel. Safewormer, Masoten, Oxfendazole and  
L-Levamisol HCI, were screened for their efficacy against Angu~lljcola crassus, a swimbladder 
nematode of European eel Anguilla anguilla. All expenments were carried out under saltwater 
conditions. Of the 6 drugs, L-Levamisole HCl used in a bath treatment gave the most promising results. 
Evaluation of the curative dose of L-Levamisole HCI showed that a long-term treatment (6 d) w ~ t h  
20 mg I - '  was far more effect~ve than a short-term treatment (24 h)  Dosages lower than 20 mg  1 - '  
showed a lower efficacy a g a ~ n s t  Anguillicola crassus. However, even with a long-term, high-dosage 
treatment, some recovery of adult nematodes with sublethal damage and/or migration of viable 
juveniles into the swimbladder lumen could not be  excluded When examined 35 d after treatment, the 
percentage of mobile adults had increased, while a decrease in percentage of dead worms was  noticed 
compared to values obtained immediately after treatment. 
INTRODUCTION 
Anguillicola crassus Kuwahara, Niimi & Itagaki, 1974 
is a swimbladder nematode of japanese eel Anguilla 
japonica, indigenous to eastern Asia. For some years 
now, A. crassus has been found in European eel 
Anguilla anguilla (Paggi et al. 1982, Van Banning et  al. 
1985, Molnar 1986, De Charleroy et  al. 1987). 
The nematode spread quickly through the wild eel 
stock in Europe due to importation of eels from the Far 
East, restocking of infested eels and natural dispersion 
(Canestri-Trotti 1987, Belpaire et  al. 1989). Wild- 
caught fingerling eels, used for stocking several com- 
mercial eelfarms in Europe, were also possibly infected 
(De Charleroy et al. 1990). Consequently, problems in 
commercial eel culture arose, and pathological effects 
induced by the parasite were investigated. Naturally 
infected eels seemed to show more severe lesions than 
experimentally infected eels (Haenen et  al. 1989). Ele- 
vated mortalities of 10 to 20 % and loss of growth in eels 
by 20 to 30% were reported (Liewes et al. 1987). 
Therefore, studies on possible treatments against the 
nematodes were strongly urged (Ghittino et al. 1989). 
Basically, 2 ways of controlling anguillicolosis were 
proposed. Firstly, prophylactic methods were used, 
whereby bodies of water are treated to eliminate the 
intermediate hosts (copepods) so that the life cycle of 
the parasites cannot be completed. Complete eradica- 
tion of the copepods seems virtually impossible, how- 
ever (De Charleroy pers. comm.). Therefore, therapeu- 
tic treatment of infested eels with anthelmintics was 
considered. 
Taraschewski et  al. (1988) examined the effects of 5 
nematocidal drugs on Anguillicola crassus adults and  
preadults, under freshwater conditions: Levamisole . 
HCl, Metrifonate, Febendazole, Mebendazole and 
Ivermectin. Three different methods of administration 
were evaluated: force-feeding, bath treatments and 
intramuscular injections. Levamisole HC1 seemed to 
be the most effective, and bath treatment with 1 mg 1-' 
per 24 h led to a complete cure. Hartmann (1989) 
investigated the long-term effects of various dosages of 
Levamisole on the different developmental stages. 
Adults and preadults showed considerable loss of vital- 
ity for 3 wk after therapy. Eggs and newly hatched 
larvae showed no reaction to the drug. According to 
Hartmann (1989), a single treatment with Levamisole 
under freshwater conditions seemed to be  ineffective 
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since some nematodes were able to regenerate after 
suffenng sublethal damage. The results mentioned 
above were all obtained with eels in freshwater. In the 
present investigation, the efficacy of 6 anthelmintic 
drugs (including Levamisole) on A crassus was evalu- 
ated under saltwater conditions in a commercial eel 
farm. 
MATERIALS AND METHODS 
Parasitized eels. The experiments were conducted at 
an eel farm in the Netherlands which used a saltwater 
recirculation system (salinity 28 to 30 ppt) for stocking 
and rearing the eels. Naturally infested eels Anguilla 
anguilla (weight 15 to 30 g) from the IJsselmeer (The 
Netherlands) were used for the experiments. 
Reinfection of the eel stock did not occur since salt- 
water is lethal for the larval stages of Anguillicola 
crassus, and no marine crustaceans are known to func- 
tion as first intermediate hosts for this nematode (De 
Charleroy et  al. 1989). Since heavily infested eels died 
and there was no reinfection of the stocked fish, the 
percentage of infestation of the stock of eels used for 
experiments declined from 78 % in July 1987 to 35 O/O in 
March 1988. The mean number of adult nematodes per 
eel during the experiments was 2.85, which represents 
a rather low level of infection. 
Selection of antiparasitical drugs. Since no anthel- 
mintics specific for fish were known at the time our 
research was conducted, anthelmintics developed for 
veterinary use in farm animals were evaluated. Drugs 
were selected using the following criteria: the drug 
should (1) be effective against haematophagous 
nematodes; (2) attain a substantial level in the blood; 
(3) be  easy to administer and be known to have a low 
toxicity; (4) be easily resorbed through the digestive 
tract or the skin; (5) be known to leave no unacceptable 
residues. 
On this basis, 6 drugs were retained (asterisks indi- 
cate the names used in this report): (1) Ivermec (1 
solution of Ivermectine'; M.S.D.-Agrivet); (2) Flukiver 
drench (5 O/O solution of Closantel'; Janssen Phar- 
maceutica); (3) Safewormer' powder (containing a 
mixture of pytanteltartrate and flubenol; Colombo, 
Hoevelaken); (4) Masoten' powder (Bayer Leverku- 
sen);  (5) Syanthic (2.265'/0 solution of Oxfendazole'; 
Syntex International, Animal Health Division); (6) 
Ripercol (10"b solution of L-Levamisole HC1'; Jans- 
sen Pharmaceutica). 
Treatment methods. In most experiments, bath treat- 
ments were used. This proved to be the best method, 
since eels that did not feed could also be treated. In 
addition, a force-feeding experiment was carried out 
with Closantel. 
Information on use of the drugs for treatment of 
fishes was minimal. Therefore, each drug was screened 
first on its toxicity to eels. Next, its efficacy against 
Anguillicola crassus was investigated. For the force- 
feeding experiment, the given dosage was based on 
the prescription for farm animals. 
Experimental conditions. Since the eels were 
stocked in a saltwater recirculation system, most treat- 
ments were carried out in saltwater (salinity 28 to 30 
ppt). Only for the bath treatment with Closantel was 
freshwater used, since this drug seemed to be insoluble 
in saltwater. About 1 wk before the experiment with 
Closantel started, the eels were transferred to fresh- 
water to adapt to the freshwater environment. 
For the first set of experiments, on toxicity and effi- 
cacy of the drugs (see Table l ) ,  a minimum of 10 eels 
per treatment was used. They were kept in aerated 
aquaria containing 8 l saltwater. In addition, aquaria 
(40 1) with about 30 eels per experimental condition 
were used in experiments to evaluate the curative dose 
of L-Levamisole HC1 (see Table 2). In both these sets 
of experiments, the eels were lulled and examined 
immediately after treatment. 
In a final experiment, in which long-term effects of L- 
Levamisole . HC1 on adult nematodes were evaluated, 
2 tanks of 30 m3 were stocked with 334 and 322 kg of 
eels respectively (mean individual weight = 32 g). One 
tank was treated on 6 consecutive days with 20 mg I-' 
L-Levamisole HC1. The other tank was used as a con- 
trol. The water in both tanks was drained and changed 
daily during treatment. Care was taken not to flush 
water containing L-Levamisole HC1 into the recircula- 
tion system. In this experiment, 30 eels were investi- 
gated from each tank 35 d after finishing the therapy, 
in order to evaluate the long-term effects of the treat- 
ment. During treatment the eels were not fed. 
Parasitological examination. After all treatments, 
eels were anaesthetized and killed with an overdose of 
Hypnodil (20 mg 1-') before the swimbladder was 
removed for examination. The swimbladder was dis- 
sected and examined for Anguillicola crassus. Adults, 
preadults, larval stage 1 (Ll ,  surrounded with egg 
membrane) and larval stage 2 (L2, hatched and very 
mobile, without egg membrane and with a long thin 
tail) were distinguished. Since we used drugs during 
the experiments which cause paralysis in nematodes 
(e.g L-Levamisole . HCl), 3 different states of vitality of 
adult and preadult A. crassus were distinguished: 
'mobile', 'immobile' (worms paralyzed but still intact) 
and 'dead' (worms disintegrated). 
The mobility of Anguillicola crassus adults and 
preadults was determined as follows: (1) the nematode 
was put in a drop of freshwater, or (2) the bottom of the 
petri dish containing the nematode was slightly heated. 
If the nematode was intact but did not respond to these 
stimuli by showing wriggling movements, ~t was consi- 
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dered 'immobile'. Occasionally, worms which had dis- 
integrated were found; these were recorded as dead. 
The mobility of larval stages 1 and 2 was examined 
with a light microscope. When there was any doubt 
about the vitality (especially for stage L1) they were 
kept in petri dishes with freshwater for 1 to 3 d and 
examined again. Under these conditions, viable larvae 
hatch and are very mobile. 
Safewormer, Oxfendazole and L-Levamisole . HC1 
were not found to be toxic. 
Considering the high toxicity of Ivermectin and 
Closantel when administered by bath, no further 
experiments on their effectiveness against Anguillicola 
crassus were carried out using bath treatments. How- 
ever, since Closantel administered by force-feeding did 
not seem to be toxic, further experiments using this 
method were conducted. 
RESULTS 
Efficacy of anthelmintics against Anguillicola crassus 
Toxicity of drugs to eels 
In the first set of experiments, 5 anthelmintic drugs 
were tested for their efficacy against Anguillicola cras- 
sus: Safewormer, Closantel, Masoten, Oxfendazole and 
L-Levamisole . HCl ( Table 1). 
Safewormer, even in high concentrations, seemed 
ineffective against the nematodes. Closantel (force- 
fed), Masoten and Oxfendazole had only a slight effect 
on Anguillicola crassus adults in comparison with L- 
Levamisole . HC1. The short-term bath treatment (24 h) 
with L-Levamisole HC1 (20 mg 1-l) left only 15 %of 
the worms mobile, while no mobile worms were found 
in the long-term bath treatment (6 d,  20 mg I-'). Con- 
sidering the difficulties in administering Closantel 
(force-feeding), the rather high toxicity of Masoten and 
the low effectiveness of Oxfendazole and Safewormer, 
no further investigations were performed with these 
products. 
Ivermectin and Closantel, administered by means of a 
bath treatment, were found to be toxic in low concen- 
trations. For Ivermectin, concentrations between 2 X 
10-4 mg 1-' and 15 X 1oP3 mg 1-l were tested. Closantel 
was tested in concentrations between 25 X 10-2 mg 1-' 
and 100 mg 1 - l .  Ivermectin induced mortality in 50 % of 
the eels at a concentration of 2 X 10-4 mg l-l after 24 h. 
The LCS0 value for Closantel, screened in freshwater, 
was 2.5 mg I- '  after 24 h. The drench form of Closantel, 
however, was not toxic when a dose of 10 mg kg-' body 
weight was administered orally in the force-feeding 
experiment. Masoten was found not to be toxic in low 
concentration (0.5 mg I-') as a bath treatment. Concen- 
trations above 2.0 mg 1-' should not be used, according 
to the instructions for farm animals distributed with the 
drug. 
Table 1. Experiments 
Concentrations in mg 1 
on eff~cacy of 5 anthelmintic drugs agalnst Anguillicola crassus adults infecting Anguilla anguilla 
- '  unless otherwise indicated. BW: Body weight; Inf.: infested; Mob.: mobile nematodes; Imm.: immobile 
but intact nematodes; Dead: decomposed nematodes; Total: % Imm. + O/O Dead 
Method Time Conc. No. of X Inf. No. of % Mob. O/O Imm. % Dead Total 
eels worms 
Safewormer Bath 5 d 0 10 100 33 
Bath 5 d 800 10 80 17 
Bath 5 d 2400 10 70 24 
Closantel 
Masoten 
Oxfendazole 
Levamisole 
Force- 
feeding 
6 d  10mg 20 
kg-' BW 
Bath 
Bath 
Bath 
Bath 
Bath 
Bath 
a Control for the treatments with Closantel, Masoten. Oxfendazole and Levamisole 
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Since L-Levamisole . HC1 is easy to administer (bath that the impact of the drug on these nematode develop- 
treatment) and has a very low toxicity for eels (LCS0 = mental stages could not be determined clearly in this 
250 mg 1-l, 24 h;  Taraschewsk~ et  al. 1988). and consid- study 
ering the rather promising results with this product, all 
further experiments were focused on the use of this Long-term effect of L-Levamisole - HC1 treatment on drug as a treatment for anguillicolosis. Anguillicola crassus adults 
In a final experiment, the long-term effects of L- Evaluation of curative dose of L-Levamisole . HCl Levamisole HCl treatment on adult nematodes were 
Further experiments were set up to determine the opti- evaluated. Thirty-five days after treatment, 30 eels 
mal curative dose of L-Levamisole . HC1, using bath were examined for viability of Anguil1icola crassus 
treatments in a saltwater system. adults. Again, L-Levamisole HC1 demonstrated effec- 
Firstly, a short-term bath treatment (24 h,  1 adminis- tiveness: when treated, 85 % of the adult A. crassus 
tration) with 20 mg 1-' L-Levamisole . HC1 was com- were paralyzed or dead, compared with only 20 % in 
pared with a long-term treatment (6 d ,  6 administra- the control group (Table 3). 
tions) (Table 1). The dose of 20 mg 1-' was selected 
based On Our previous findings which showed that Table 3. Evaluation of long-term effects of L-Levamisole HCI 
higher doses of L-Levamisole . HC1 did not result in treatment (20 mg 1-1, 6 d)  on Angujlljcola crassus infecting 
higher immobilization of Anguillicola crassus (data not Anguilla anguilla. Abbreviations as in Table 1 
shown). The long-term treatment clearly gave better 
results than the short-term treatment. When treated 
with 20 mg I-' L-Levamisole. HCl for 6 consecutive immediately after 35 d after 
days, all eels were free of mobile A. crassus adults. In treatment treatment 
contrast, 15 % of the nematodes were still mobile when Controla Treateda Control Treated 
only a short-term treatment of 24 h with the same 
concentration was carried out. 
Secondly, long-term bath treatments (6 d) with vary- 
ing concentrations of L-Levamisole . HCl (2.5, 5.0, 10.0 
Table 2. Evaluation of curative dose of L-Levamisole.HC1, 
when used in long-term bath treatment (6 d ) ,  for Anguilljcola 
crassus infecting Anguilla angullla. Column headings as in 
Table 1 
No. of eels 3 6 4 0 3 0 3 0 
O/O Inf. 53 35 3 6 3 6 
NO, of,o,ms 39 27 20 20 
O/O Mob. 88.5 2.5 80.0 15.0 
and 20 mg 1-l) were tested to determine if concen- 
tratlons lower than 20 mg I- '  would be sufficient to 
paralyze the nematodes (Table 2). Treatments of 6 d 
Conc. No. O/O No. % O/O % Total 
(mgl- ')  of Inf. of Mob. Imm. Dead 
worms 
% Imm. 0.0 75.0 0.0 
'I0 Dead 11.5 22.5 20.0 
" Results from 2 samples combined 
with concentrations lower than 20 mg 1-' showed a 
much lower efficacy agalnst Anguillicola crassus. 
When treated with 20 mg 1-' L-Levamisole HC1, 95 % 
of A. crassus adults were immobile or dead, whereas 
only up to 78.6 O/O of the adults were immobilized or 
dead after treatment with lower concentrations. 
Unfortunately, the prevalence of preadult and larval 
stages during the Levamisole experiments was so low 
These results were compared with those from the 
former experiments, in which the nematodes were 
checked immediately after treatment. In all experi- 
ments used for this comparison, the same L-Levamisole 
HCl therapy was given (20 mg I-', 6 d) - only the 
period between therapy and examination differed. 
Immediately after treatment only 2.5% of the adults 
were found mobile, while this value reached 15 O/O 
when checked 35 d after treatment. The percentage of 
dead nematodes declined, however: while 22.5 % of 
the nematodes were found dead when checked 
immediately after therapy, only 15 % were found dead 
35 d after treatment. Thus, disintegration of the para- 
lyzed worms apparently did not increase. 
DISCUSSION 
Out of 6 anthelmintics which were tested as  possible 
drugs against Anguillicola crassus under saltwater con- 
ditions, L-Levamisole . HC1 seemed the most effective. 
The other drugs were either found to be too toxic for 
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eels (Ivermectin and Closantel, bath treatment) or too 
difficult to administer (Closantel, force-feeding), or had 
too low an efficacy against A. crassus [Safewormer, 
Masoten, Oxfendazole (bath treatments), Closantel 
(force-feeding)]. Taraschewski et al. (1988) also noted 
the high toxicity of Ivermectin. They used intramuscu- 
lar injections, but the eels died within 2 wk, whereas 
the worms survived. These investigators found L- 
Levamisole . HC1 to be  the most effective drug for 
treatment of eels in a freshwater environment. 
To assess the optin~al curative dose of L-Levamisole 
HC1, it was necessary for us to focus on various dosages 
and times of exposure. Taraschewski et  al. (1988) also 
tested different dosages and exposure times. Although 
their results served as  a useful basis for further 
research, caution had to be exercised in drawing con- 
clusions because of the low number of eels used per 
experimental condition. Our experiments showed that 
a long-term bath treatment of 6 consecutive days with 
20 mg I-' L-Levamisole HCI was much more effective 
than a short-term treatment (24 h )  with the same con- 
centration. When different dosages were tested in a 
long-term treatment of 6 d ,  all dosages lower than 20 
mg l-' showed lower efficacy against Anguillicola cras- 
sus. Under saltwater conditions, a bath treatment of 6 
consecutive days with 20 mg 1-' seemed to give optimal 
results. This contradicts results of Taraschewski et  al. 
(1988) for freshwater experiments in which a 24 h bath 
treatment of 1 mg I-' led to a complete cure. According 
to Hartmann (1989), who also conducted his study in 
freshwater, a higher concentration of L-Levamisole 
HCl (5 mg I-', 24 h) worked faster and effected higher 
short-term nematode mortality than a lower dosage (2 
mg 1-', 24 h), which was in accordance with our find- 
ings. The use of a high dosage (20 mg I-'), such as in 
our experiments, will obviously cause high short-term 
mortality among A. crassus adults. However, one 
should be cautious not to draw quick conclusions about 
the optimal curative dose, because the effect of a 
therapy, checked immediately after treatment, can dif- 
fer completely when rechecked some weeks later. 
Hartmann (1989) showed that some of the nematodes 
are able to regenerate after suffering sublethal dam- 
age. He noticed a n  increase in the number of intact 
nematodes about 3 wk after treatment with L- 
Levamisole . HC1. This would be  due to the recovery of 
preadults and adults and the migration of surviving 
juveniles into the lumen of the swimbladder. As indi- 
cated by our experiments, long-term treatment (6 d) 
with a high dosage (20 mg 1-l) will most probably have 
a long and severe impact on the viable nematodes, 
more nematodes will suffer lethal damage and,  subse- 
quently, recovery from sublethal damage will be much 
lower than after a short-term, low-dosage treatment. 
Nonetheless, the percentage of mobile worms found 
35 d after treatment was higher than when checked 
immediately after therapy. These results suggest that, 
even after long-term high-dosage treatment, a degree 
of recovery and migration of viable juveniles into the 
swimbladder lumen cannot b e  excluded. 
Furthermore, the number of dead worms 35 d after 
treatment was lower than that immediately after treat- 
ment. Hartmann (1989) explained this decrease in 
dead,  disintegrated worms as a result of ejection of 
their remains from the eels through the ductus 
pneumaticus. This could not, however, be verified in 
our experiments, since w e  used commercial tanks with 
a high density of eels for this experiment. 
Our results show that, although a long-term treat- 
ment using a high dosage of L-Levamisole . HCl seems 
quite efficacious against adult Anguillicola crassus ini- 
tially, it will probably be  ineffective if not followed by 
subsequent treatments. In accordance with Hartmann's 
recommendation (1989), a second treatment scheduled 
about 3 wk after the first, and possibly other treatments 
later at longer time intervals, seem advisable. The 
advantage of a saltwater system (as in our experiments) 
over a freshwater system is that no reinfection of the eel 
stock occurs, since nematode larvae do not survive 
saline conditions and no suitable intermediate hosts are 
present. 
Although L-Levamisole HC1 seems to be a very 
promising drug in the treatment of anguillicolosis, more 
data should be gathered about the residues of the drug 
in the fish flesh, and its effects on consumability of the 
eels, before it can be used in commercial eel farms on a 
large scale. 
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